233 related articles for article (PubMed ID: 1648728)
1. Retinoic acid is a negative regulator of AP-1-responsive genes.
Schüle R; Rangarajan P; Yang N; Kliewer S; Ransone LJ; Bolado J; Verma IM; Evans RM
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6092-6. PubMed ID: 1648728
[TBL] [Abstract][Full Text] [Related]
2. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
3. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone.
Jonat C; Rahmsdorf HJ; Park KK; Cato AC; Gebel S; Ponta H; Herrlich P
Cell; 1990 Sep; 62(6):1189-204. PubMed ID: 2169351
[TBL] [Abstract][Full Text] [Related]
4. Induction of retinoid resistance in breast cancer cells by overexpression of cJun.
Yang L; Kim HT; Munoz-Medellin D; Reddy P; Brown PH
Cancer Res; 1997 Oct; 57(20):4652-61. PubMed ID: 9377582
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.
Yang-Yen HF; Chambard JC; Sun YL; Smeal T; Schmidt TJ; Drouin J; Karin M
Cell; 1990 Sep; 62(6):1205-15. PubMed ID: 2169352
[TBL] [Abstract][Full Text] [Related]
6. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
Wan H; Hong WK; Lotan R
Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional control of c-jun by retinoic acid.
de Groot RP; Pals C; Kruijer W
Nucleic Acids Res; 1991 Apr; 19(7):1585-91. PubMed ID: 1851295
[TBL] [Abstract][Full Text] [Related]
8. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription.
Owen TA; Bortell R; Yocum SA; Smock SL; Zhang M; Abate C; Shalhoub V; Aronin N; Wright KL; van Wijnen AJ
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9990-4. PubMed ID: 2124710
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of collagenase gene expression by retinoic acid receptors--alpha, beta and gamma.
Pan L; Chamberlain SH; Auble DT; Brinckerhoff CE
Nucleic Acids Res; 1992 Jun; 20(12):3105-11. PubMed ID: 1320254
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of rabbit collagenase (matrix metalloproteinase-1; MMP-1) transcription by retinoid receptors: evidence for binding of RARs/RXRs to the -77 AP-1 site through interactions with c-Jun.
Schroen DJ; Brinckerhoff CE
J Cell Physiol; 1996 Nov; 169(2):320-32. PubMed ID: 8908199
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.
Salbert G; Fanjul A; Piedrafita FJ; Lu XP; Kim SJ; Tran P; Pfahl M
Mol Endocrinol; 1993 Oct; 7(10):1347-56. PubMed ID: 8264664
[TBL] [Abstract][Full Text] [Related]
12. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.
Chen JY; Penco S; Ostrowski J; Balaguer P; Pons M; Starrett JE; Reczek P; Chambon P; Gronemeyer H
EMBO J; 1995 Mar; 14(6):1187-97. PubMed ID: 7720709
[TBL] [Abstract][Full Text] [Related]
13. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor.
Schüle R; Rangarajan P; Kliewer S; Ransone LJ; Bolado J; Yang N; Verma IM; Evans RM
Cell; 1990 Sep; 62(6):1217-26. PubMed ID: 2169353
[TBL] [Abstract][Full Text] [Related]
14. Antagonism between retinoic acid receptors and AP-1: implications for tumor promotion and inflammation.
Yang-Yen HF; Zhang XK; Graupner G; Tzukerman M; Sakamoto B; Karin M; Pfahl M
New Biol; 1991 Dec; 3(12):1206-19. PubMed ID: 1667479
[TBL] [Abstract][Full Text] [Related]
15. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
16. The PML-retinoic acid receptor alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1.
Doucas V; Brockes JP; Yaniv M; de Thé H; Dejean A
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9345-9. PubMed ID: 8415704
[TBL] [Abstract][Full Text] [Related]
17. Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene.
Schüle R; Umesono K; Mangelsdorf DJ; Bolado J; Pike JW; Evans RM
Cell; 1990 May; 61(3):497-504. PubMed ID: 2159384
[TBL] [Abstract][Full Text] [Related]
18. A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors.
Desbois C; Aubert D; Legrand C; Pain B; Samarut J
Cell; 1991 Nov; 67(4):731-40. PubMed ID: 1682056
[TBL] [Abstract][Full Text] [Related]
19. Ligand-dependent activation of transcription in vitro by retinoic acid receptor alpha/retinoid X receptor alpha heterodimers that mimics transactivation by retinoids in vivo.
Dilworth FJ; Fromental-Ramain C; Remboutsika E; Benecke A; Chambon P
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1995-2000. PubMed ID: 10051583
[TBL] [Abstract][Full Text] [Related]
20. Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid.
Wu S; Zhang D; Zhang ZP; Soprano DR; Soprano KJ
Oncogene; 1998 Dec; 17(22):2839-49. PubMed ID: 9879990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
